Page last updated: 2024-10-28

hydroxyurea and Behcet Syndrome

hydroxyurea has been researched along with Behcet Syndrome in 4 studies

Behcet Syndrome: Rare chronic inflammatory disease involving the small blood vessels. It is of unknown etiology and characterized by mucocutaneous ulceration in the mouth and genital region and uveitis with hypopyon. The neuro-ocular form may cause blindness and death. SYNOVITIS; THROMBOPHLEBITIS; gastrointestinal ulcerations; RETINAL VASCULITIS; and OPTIC ATROPHY may occur as well.

Research Excerpts

ExcerptRelevanceReference
"In two patients with Behcet's disease (BD) and rheumatoid arthritis (RA), CML developed after RD, in two patients with diffuse cutaneous systemic sclerosis and spondyloarthropathy, RD was diagnosed after CML."2.43Rheumatic diseases and chronic myelogenous leukemia, presentation of four cases and review of the literature. ( Aydogdu, I; Erkurt, MA; Kaya, E; Kuku, I; Senel, S, 2006)
"Treatment with hydroxyurea was started in 1997, which stabilized the platelet count."1.33[Essential thrombocythemia associated with incomplete type intestinal Behçet disease during hydroxyurea treatment]. ( Fujimi, A; Iyama, S; Kato, J; Kikuchi, S; Kobune, M; Kuribayashi, K; Matsunaga, T; Murase, K; Niitsu, Y; Okamoto, T; Satoh, T; Takimoto, R; Ueno, A, 2005)
"Hydroxyurea has been implicated in the appearance of skin vasculitic ulceration, but this is the first case, according to our knowledge, where the development of BD was observed during hydroxyurea maintenance in the chronic phase of CML."1.31Behcet's disease in a patient with chronic myelogenous leukemia under hydroxyurea treatment: a case report and review of the literature. ( Loukopoulos, D; Nodaros, K; Rombos, J; Terpos, E; Vaiopoulos, G; Viniou, N, 2001)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Karincaoglu, Y1
Kaya, E2
Esrefoglu, M1
Aydogdu, I2
Senel, S1
Erkurt, MA1
Kuku, I1
Kobune, M1
Kato, J1
Kuribayashi, K1
Iyama, S1
Fujimi, A1
Murase, K1
Ueno, A1
Kikuchi, S1
Satoh, T1
Okamoto, T1
Takimoto, R1
Matsunaga, T1
Niitsu, Y1
Vaiopoulos, G1
Terpos, E1
Viniou, N1
Nodaros, K1
Rombos, J1
Loukopoulos, D1

Reviews

2 reviews available for hydroxyurea and Behcet Syndrome

ArticleYear
Development of large genital ulcer due to hydroxyurea treatment in a patient with chronic myeloid leukemia and Behcet's disease.
    Leukemia & lymphoma, 2003, Volume: 44, Issue:6

    Topics: Adult; Antineoplastic Agents; Behcet Syndrome; Female; Genital Diseases, Female; Humans; Hydroxyurea

2003
Rheumatic diseases and chronic myelogenous leukemia, presentation of four cases and review of the literature.
    Rheumatology international, 2006, Volume: 26, Issue:9

    Topics: Adult; Aged; Behcet Syndrome; Female; Humans; Hydroxyurea; Leukemia, Myelogenous, Chronic, BCR-ABL P

2006

Other Studies

2 other studies available for hydroxyurea and Behcet Syndrome

ArticleYear
[Essential thrombocythemia associated with incomplete type intestinal Behçet disease during hydroxyurea treatment].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2005, Volume: 46, Issue:10

    Topics: Aged; Behcet Syndrome; Biomarkers; HLA-B Antigens; HLA-B51 Antigen; Humans; Hydroxyurea; Male; Throm

2005
Behcet's disease in a patient with chronic myelogenous leukemia under hydroxyurea treatment: a case report and review of the literature.
    American journal of hematology, 2001, Volume: 66, Issue:1

    Topics: Antineoplastic Agents; Behcet Syndrome; Fatal Outcome; Female; HLA-B Antigens; Humans; Hydroxyurea;

2001
chemdatabank.com